亚太地区胰岛素输送设备市场 - 增长、趋势、COVID-19 影响和预测(2022 - 2027 年)

市场按产品(可重复使用的胰岛素笔芯、一次性胰岛素笔、胰岛素注射器、胰岛素喷射注射器、胰岛素泵)和地理位置进行细分。

市场快照

Asia-Pacific Insulin Delivery Devices Market Size
Study Period: 2016-2027
Base Year: 2021
CAGR: >3 %
Asia-Pacific Insulin Delivery Devices Market Key Players

Need a report that reflects how COVID-19 has impacted this market and its growth?

市场概况

预计亚太地区胰岛素输送设备市场在预测期内的复合年增长率将超过 3%。近年来,亚太地区的糖尿病患者患病率惊人地增加。对胰岛素不断增长的需求导致在制造不同的、无痛类型的胰岛素输送设备方面进行了大量研发,例如 CGM 集成胰岛素泵。传统上,胰岛素注射器是胰岛素输送系统的唯一形式,被认为是痛苦的并且不方便用户使用。此外,剂量可能不准确。因此,诺和诺德和赛诺菲等公司已经在市场上购买了他们的胰岛素笔。这些笔具有一组特定的剂量,被认为不仅使用起来不那么痛苦,而且还减少了胰岛素的浪费。

报告范围

该研究对亚太地区的胰岛素输送设备市场进行了详细分析,包括市场份额、规模、预测和行业概况。

By Product (Value and Volume, 2016 - 2026)
Cartridges in Reusable Insulin Pens
Disposable Insulin Pens
Insulin Syringes
Insulin Jet Injectors
Insulin Pump
Insulin Pump Device
Insulin Pump Reservoir
Infusion Set
Geography (Value and Volume, 2016 - 2026)
Asia-Pacific
Australia
By product (Cartridges in Reusable Insulin Pens, Disposable Insulin Pens, Insulin Syringes, Insulin Jet Injectors, Insulin Pump)
India
By product (Cartridges in Reusable Insulin Pens, Disposable Insulin Pens, Insulin Syringes, Insulin Jet Injectors, Insulin Pump)
Indonesia
By product (Cartridges in Reusable Insulin Pens, Disposable Insulin Pens, Insulin Syringes, Insulin Jet Injectors, Insulin Pump)
Thailand
By product (Cartridges in Reusable Insulin Pens, Disposable Insulin Pens, Insulin Syringes, Insulin Jet Injectors, Insulin Pump)
Philippines
By product (Cartridges in Reusable Insulin Pens, Disposable Insulin Pens, Insulin Syringes, Insulin Jet Injectors, Insulin Pump)
Vietnam
By product (Cartridges in Reusable Insulin Pens, Disposable Insulin Pens, Insulin Syringes, Insulin Jet Injectors, Insulin Pump)
China
By product (Cartridges in Reusable Insulin Pens, Disposable Insulin Pens, Insulin Syringes, Insulin Jet Injectors, Insulin Pump)
South Korea
By product (Cartridges in Reusable Insulin Pens, Disposable Insulin Pens, Insulin Syringes, Insulin Jet Injectors, Insulin Pump)
Japan
By product (Cartridges in Reusable Insulin Pens, Disposable Insulin Pens, Insulin Syringes, Insulin Jet Injectors, Insulin Pump)
Malaysia
By product (Cartridges in Reusable Insulin Pens, Disposable Insulin Pens, Insulin Syringes, Insulin Jet Injectors, Insulin Pump)
Rest of Asia-Pacific
By product (Cartridges in Reusable Insulin Pens, Disposable Insulin Pens, Insulin Syringes, Insulin Jet Injectors, Insulin Pump)

Report scope can be customized per your requirements. Click here.

主要市场趋势

2020年日本在亚太地区胰岛素输送设备市场占据主要市场份额

日本占亚太地区胰岛素输送设备市场 41% 的市场份额。在日本、中国和印度等发展中国家,人口中的糖尿病发病率一直在增长,这主要是由于人口不健康的生活方式。在日本,不断增长的老年人口正在推动胰岛素输送设备市场的发展。不断变化的生活方式趋势,加上人口的高可支配收入,是胰岛素输送设备销售的一些突出驱动因素。胰岛素最初被认为是仅用于 1 型患者的治疗方法。然而,多年来,胰岛素也被相当多的 2 型患者用作治疗线。

Asia-Pacific Insulin Delivery Devices Market Trends

通过一次性笔输送胰岛素在亚太地区的市场份额最高。

2020 年亚太地区一次性使用胰岛素笔的市场价值为 66 亿美元,占市场份额的 39%。这包含一个预填充的胰岛素药筒。一旦使用,整个笔单元将被丢弃。笔和墨盒中的胰岛素通常比瓶装胰岛素和注射器更昂贵。众所周知,可重复使用笔中的胰岛素药筒是胰岛素笔的必要扩展。当使用笔时,会浪费少量的胰岛素,从而降低该过程的经济性。一大群 1 型糖尿病患者是儿童。需要替代现有的基于针头的递送系统,这是痛苦的,因此,引入了胰岛素喷射注射器的发明,一种无痛的胰岛素递送系统。大多数类型的胰岛素都是以药筒的形式制造的,因此很容易获得。​这些设备具有可重复使用的笔的所有功能优势并且具有成本效益,因为从长远来看,与一次性胰岛素笔相比,这些药筒更便宜。​​​

Asia-Pacific Insulin Delivery Devices Market Growth

竞争格局

市场整合,2020 年很少有参与者占据重要市场份额。然而,胰岛素注射器市场高度分散,许多市场参与者都在本地。扩大市场占有率的公司正在投资研发,并与其他主要参与者合作开发创新解决方案。雅培和诺和诺德建立合作伙伴关系,以便使用胰岛素为糖尿病患者提供集成的数字解决方案。此次合作可以使诺和诺德的互联胰岛素笔和与 FreeStyle Libre 产品组合兼容的数字健康工具之间共享胰岛素数据。Tandem 的 Control-IQ 系统于 2019 年底获得 FDA 批准,并于 2020 年 1 月向客户推出。

RECENT DEVELOPMENTS

In June 2021, Medtronic Korea agreed with Handok to increase the supply of its medical devices for diagnosing and treating diabetes in Korea. The two companies said they signed the deal to introduce differentiated diabetes diagnosis and advanced treatment solutions to Korean patients based on their expertise in the field. Handok will be marketing Medtronic’s continuous glucose monitoring (CGM) system, insulin pump, direct infusion device, and other medical products related to diabetes. Handok had been supplying Medtronic’s CGM systems, Guardian Connect and iPro-2, since June 2019. The recent agreement added insulin pump MiniMed 640G, direct infusion device i-Port Advance, and MiniMed 770G.

Table of Contents

  1. 1. INTRODUCTION

    1. 1.1 Study Assumptions

    2. 1.2 Scope of the Study

  2. 2. RESEARCH METHODOLOGY

  3. 3. EXECUTIVE SUMMARY

  4. 4. MARKET DYNAMICS

    1. 4.1 Market Overview

    2. 4.2 Market Drivers

    3. 4.3 Market Restraints

    4. 4.4 Porter's Five Forces Analysis

      1. 4.4.1 Bargaining Power of Suppliers

      2. 4.4.2 Bargaining Power of Consumers

      3. 4.4.3 Threat of New Entrants

      4. 4.4.4 Threat of Substitute Products and Services

      5. 4.4.5 Intensity of Competitive Rivalry

  5. 5. Market Segmentation

    1. 5.1 By Product (Value and Volume, 2016 - 2026)

      1. 5.1.1 Cartridges in Reusable Insulin Pens

      2. 5.1.2 Disposable Insulin Pens

      3. 5.1.3 Insulin Syringes

      4. 5.1.4 Insulin Jet Injectors

      5. 5.1.5 Insulin Pump

        1. 5.1.5.1 Insulin Pump Device

        2. 5.1.5.2 Insulin Pump Reservoir

        3. 5.1.5.3 Infusion Set

    2. 5.2 Geography (Value and Volume, 2016 - 2026)

      1. 5.2.1 Asia-Pacific

        1. 5.2.1.1 Australia

          1. 5.2.1.1.1 By product (Cartridges in Reusable Insulin Pens, Disposable Insulin Pens, Insulin Syringes, Insulin Jet Injectors, Insulin Pump)

        2. 5.2.1.2 India

          1. 5.2.1.2.1 By product (Cartridges in Reusable Insulin Pens, Disposable Insulin Pens, Insulin Syringes, Insulin Jet Injectors, Insulin Pump)

        3. 5.2.1.3 Indonesia

          1. 5.2.1.3.1 By product (Cartridges in Reusable Insulin Pens, Disposable Insulin Pens, Insulin Syringes, Insulin Jet Injectors, Insulin Pump)

        4. 5.2.1.4 Thailand

          1. 5.2.1.4.1 By product (Cartridges in Reusable Insulin Pens, Disposable Insulin Pens, Insulin Syringes, Insulin Jet Injectors, Insulin Pump)

        5. 5.2.1.5 Philippines

          1. 5.2.1.5.1 By product (Cartridges in Reusable Insulin Pens, Disposable Insulin Pens, Insulin Syringes, Insulin Jet Injectors, Insulin Pump)

        6. 5.2.1.6 Vietnam

          1. 5.2.1.6.1 By product (Cartridges in Reusable Insulin Pens, Disposable Insulin Pens, Insulin Syringes, Insulin Jet Injectors, Insulin Pump)

        7. 5.2.1.7 China

          1. 5.2.1.7.1 By product (Cartridges in Reusable Insulin Pens, Disposable Insulin Pens, Insulin Syringes, Insulin Jet Injectors, Insulin Pump)

        8. 5.2.1.8 South Korea

          1. 5.2.1.8.1 By product (Cartridges in Reusable Insulin Pens, Disposable Insulin Pens, Insulin Syringes, Insulin Jet Injectors, Insulin Pump)

        9. 5.2.1.9 Japan

          1. 5.2.1.9.1 By product (Cartridges in Reusable Insulin Pens, Disposable Insulin Pens, Insulin Syringes, Insulin Jet Injectors, Insulin Pump)

        10. 5.2.1.10 Malaysia

          1. 5.2.1.10.1 By product (Cartridges in Reusable Insulin Pens, Disposable Insulin Pens, Insulin Syringes, Insulin Jet Injectors, Insulin Pump)

        11. 5.2.1.11 Rest of Asia-Pacific

          1. 5.2.1.11.1 By product (Cartridges in Reusable Insulin Pens, Disposable Insulin Pens, Insulin Syringes, Insulin Jet Injectors, Insulin Pump)

  6. 6. MARKET INDICATORS

    1. 6.1 Type-1 Diabetes Population (2016 - 2026)

    2. 6.2 Type-2 Diabetes Population (2016 - 2026)

  7. 7. COMPETITIVE LANDSCAPE

    1. 7.1 Company Profiles

      1. 7.1.1 Becton and Dickenson

      2. 7.1.2 Medtronic

      3. 7.1.3 Insulet

      4. 7.1.4 Tandem

      5. 7.1.5 Ypsomed Holding

      6. 7.1.6 Novo Nordisk

      7. 7.1.7 Sanofi

      8. 7.1.8 Eli Lilly and Company

  8. 8. MARKET OPPORTUNITIES AND FUTURE TRENDS

You can also purchase parts of this report. Do you want to check out a section wise price list?

Frequently Asked Questions

The Asia-Pacific Insulin Delivery Devices Market market is studied from 2016 - 2027.

The Asia-Pacific Insulin Delivery Devices Market is growing at a CAGR of >3% over the next 5 years.

The Asia-Pacific Insulin Delivery Devices Market is valued at 16 Billion USD in 2016.

The Asia-Pacific Insulin Delivery Devices Market is valued at 20 Billion USD in 2027.

Novo Nordisk, Medtronic, Sanofi, Eli Lilly and Company, Ypsomed Holding are the major companies operating in Asia-Pacific Insulin Delivery Devices Market.

80% of our clients seek made-to-order reports. How do you want us to tailor yours?

Please enter a valid email id!

Please enter a valid message!